Hints and tips:
Related Special Reports
...Kathrin Jansen, Pfizer’s head of vaccine research and development....
...Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, defended the organisation against accusations it had been slow to issue full legal approval....
...Convictions for honest services fraud and violations of the Controlled Substances act were overruled by the judge in November....
...Inc....
...Wyoming were added to the list this week — even though that has piled further damage on the city’s moribund tourism and services industries....
...In Trauma Center you play a surgeon using touch controls to slice and suture....
...And in New York, which is fast becoming one of the global epicentres of the disease, the city’s emergency services received more medical calls than they did on September 11 2001....
...‘Opioids, Inc.’ — now streaming, and premiering Tuesday, June 23 on PBS....
...Cases like this show the progress China has made in protecting consumer data and privacy, according to Yi Zeng, head of AI ethics and safety at the Chinese Academy of Sciences....
...Adding to the city’s academic and research clout is the University of Pittsburgh, a life sciences leader, and the University of Pittsburgh Medical Center (UPMC), which announced last year it would put $2bn...
...Three questions We spoke to Ann Aerts, head of the Novartis Foundation, which has backed the Global Partnership for Zero Leprosy. Why are you launching this partnership?...
...Scott Gottlieb, the new head of the US Food and Drug Administration, accused Big Pharma this week of “gaming the system” to block generic competition and said he hoped to cut the time for generic drug reviews...
...Tom Frieden, the former head of the US Centers for Disease Control and previously New York City's health commissioner, is well placed to try....
...He has had two longer periods without a roof over his head before, one of which lasted a year and a half....
...The Carter Center’s work against guinea worm, headed by Ruiz-Tiben, has made good progress....
...The Villar property group is building the first of what it hopes will be a chain of medical centers near its residential holdings....
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
...Jeroen Tas, head of healthcare informatics at the Dutch group, says gimmicky fitness gadgets for the “worried well” are being superseded by medical-grade technology capable of improving outcomes and reducing...
...Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York, says Mr Shkreli’s aggressive approach is the natural consequence of a US system that...
...Obamacare, which flipped the business model of health insurance on its head and revamped how the government pays healthcare providers for services rendered....
...“The whole immuno-oncology area is exploding,” says John LaMattina, former head of research and development for Pfizer....
...to deploy users’ information across a wider range of services, or risk substantial fines....
...Susan Kilsby Susan Kilsby went straight to Wall Street from Wellesley when, set to embark on a medical career, she had her head turned by the legendary M&A team of Bruce Wasserstein and Joe Perella at First...
...for others WellPoint was placed in the position of playing down its $2.7bn fourth-quarter profits and explaining why the costs of its services far exceed inflation....
...“It was a bit like drinking several glasses of sand each day,” recalls Rory Collins, head of the clinical trial service unit at Oxford University and a leading authority in the field....
International Edition